Roxithromycin is NOT Recommended Over Amoxicillin for Streptococcal Pharyngitis
Amoxicillin remains the preferred first-line treatment for group A streptococcal pharyngitis, and roxithromycin (a macrolide) should only be considered as an alternative in penicillin-allergic patients. 1
Why Amoxicillin is Superior
The 2012 IDSA guidelines explicitly state that penicillin or amoxicillin is the recommended drug of choice based on:
- Narrow spectrum of activity (reduces antimicrobial resistance)
- Infrequency of adverse reactions
- Modest cost
- Proven efficacy and safety
- No documented penicillin resistance in Group A Streptococcus 1, 2
Amoxicillin is FDA-approved for upper respiratory tract infections caused by Streptococcus species, including streptococcal pharyngitis 2. The standard regimen is 10 days of treatment to achieve maximal pharyngeal eradication of GAS.
Roxithromycin's Limited Role
Roxithromycin, as a macrolide antibiotic, falls into the category of second-line agents reserved for penicillin-allergic patients. The IDSA guidelines recommend macrolides (clarithromycin for 10 days or azithromycin for 5 days) only when patients cannot tolerate penicillin or amoxicillin 1.
Evidence Comparing the Two:
The available research comparing roxithromycin to amoxicillin shows:
No superiority for roxithromycin: A 2002 double-blind RCT in lower respiratory tract infections found that roxithromycin showed no surplus value over amoxicillin, with amoxicillin remaining "a reliable first-choice antibiotic" 3
Similar efficacy but broader spectrum concerns: While a 1992 study showed similar clinical response rates (96% vs 95%), this doesn't justify using a broader-spectrum macrolide when narrow-spectrum amoxicillin is equally effective 4
Critical Considerations
Antimicrobial Stewardship
Using broad-spectrum antibiotics like macrolides when narrow-spectrum agents work equally well contributes to:
- Development of antibiotic-resistant organisms
- Disruption of normal flora
- Increased healthcare costs
There is significant resistance to macrolides (azithromycin and clarithromycin) in some parts of the United States 5, making their routine use even more problematic.
When to Consider Macrolides (Including Roxithromycin)
Only use macrolides for streptococcal pharyngitis when:
- Documented penicillin allergy (non-anaphylactic reactions can use first-generation cephalosporins instead)
- True anaphylactic penicillin allergy where cephalosporins are also contraindicated 1
Clinical Algorithm
Confirm GAS pharyngitis with rapid antigen test or culture
Assess penicillin allergy status:
Roxithromycin would only fit in the third category as a macrolide alternative
Bottom Line
There is no evidence-based justification for choosing roxithromycin over amoxicillin as first-line therapy for streptococcal pharyngitis. The guideline-recommended approach prioritizes amoxicillin for its narrow spectrum, proven efficacy, safety profile, and role in antimicrobial stewardship 1, 6. Recent evidence even questions whether antibiotics provide substantial benefit beyond symptom reduction of 1-2 days 7, making the choice of the narrowest effective spectrum even more critical when treatment is indicated.